These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14290540)

  • 1. [RESULTS OF A CARDIOTONIC THERAPY WITH DESACETYL-LANATOSIDE C].
    MALAGUTI R
    Minerva Med; 1965 Apr; 56():1142-6. PubMed ID: 14290540
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE USE OF DESACETYL-LANATOSIDE C IN THE TREATMENT OF CARDIAC INSUFFICIENCY].
    ANTONELLI S; FERRERA U
    Gazz Med Ital; 1964 Oct; 123():312-4. PubMed ID: 14225094
    [No Abstract]   [Full Text] [Related]  

  • 3. [CLINICAL EXPERIENCE WITH A NEW CARDIOACTIVE GLYCOSIDE: DESACETYL-LANATOSIDE C].
    BOSISIO P
    Clin Ter; 1964 Mar; 28():544-61. PubMed ID: 14142763
    [No Abstract]   [Full Text] [Related]  

  • 4. [DESACETYL-LANATOSIDE C IN THERAPY OF HEART DECOMPENSATION].
    BALDACCI G; PASINI P
    Minerva Cardioangiol; 1965 Jun; 13():358-61. PubMed ID: 14346238
    [No Abstract]   [Full Text] [Related]  

  • 5. [RAPID DIGITALIZATION AND MAINTENANCE WITH DESACETYL-LANATOSIDE C; CLINICAL OBSERVATIONS].
    MRLLONI GF; DODESINI G; MARANGONI E
    Minerva Med; 1963 Nov; 54():3560-78. PubMed ID: 14126387
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contribution to cardiotonic therapy by oral route with deacetyl-lanatoside C and diethlamino-phenyl-ethylbarbiturate].
    FANCINI P
    Gazz Med Ital; 1961 Dec; 120():479-82. PubMed ID: 13891504
    [No Abstract]   [Full Text] [Related]  

  • 7. [OBSERVATIONS ON THE ACTIVITY OF A NEW DIGITALIC PRODUCT (DESACETYL-LANATOSIDE C) IN THE TREATMENT OF CARDIAC INSUFFICIENCY].
    GOLINELLI G; MELLI A
    Minerva Med; 1963 Dec; 54():3780-4. PubMed ID: 14118251
    [No Abstract]   [Full Text] [Related]  

  • 8. [ON THE CLINICAL USE OF DESACETYL-LANATOSIDE C].
    BENEDETTI G; MENICAGLI V
    Gazz Med Ital; 1963 Jul; 122():214-7. PubMed ID: 14046322
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of desacetyl-lanatoside C on cardiac output, coronary flow and O2 consumption of the dog heart in situ].
    MARCHETTI G; MERLO L
    Arch Ital Sci Farmacol; 1962 Apr; 12():135-40. PubMed ID: 13932846
    [No Abstract]   [Full Text] [Related]  

  • 10. [CONTRIBUTION TO THE CLINICAL STUDY OF THE THERAPEUTIC EFFECTS OF DESACETYL-LANATOSIDE C].
    MAGGI A
    Gazz Med Ital; 1964 Jun; 123():175-8. PubMed ID: 14174578
    [No Abstract]   [Full Text] [Related]  

  • 11. [Subcellular distribution of desacetyl-lanatoside C in the isolated guinea-pig heart].
    Marzo A; Ghirardi P; Lombardo A; Preti A
    Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1598-601. PubMed ID: 4458746
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biliary and urinary elimination of desacetyl-lanatoside C in anesthetized guinea pigs].
    Ghirardi P; Marzo A
    Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1610-1. PubMed ID: 4458748
    [No Abstract]   [Full Text] [Related]  

  • 13. [Subcellular distribution of desacetyl-lanatoside C, ouabain and digitoxin in the liver of awake guinea pigs].
    Marzo A; Ghirardi P; Lombardo A; Preti A
    Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1606-9. PubMed ID: 4458747
    [No Abstract]   [Full Text] [Related]  

  • 14. Cortical control of neurally-mediated arrhythmogenic properties of desacetyl lanatoside C: the role of the posterior hypothalamus.
    De Luca B; Cerciello A; Monda M
    Neuropharmacology; 1982 Nov; 21(11):1211-4. PubMed ID: 7177346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DETERMINATION OF TAKADIASTASE ACTIVITY TOWARDS DESACETYL LANATOSIDES].
    HORAK P
    Cesk Farm; 1964 Mar; 13():114-7. PubMed ID: 14144550
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of a new cardiotonic drug, desacetyl-lanatoside C].
    Warembourg H; Bertrand ME; Ducloux G
    Lille Med; 1972 Feb; 17():Suppl 2:169-72. PubMed ID: 5034397
    [No Abstract]   [Full Text] [Related]  

  • 17. [Usefulness of serial determinations of blood digoxin in the management of cardiotonic therapy].
    Macarie C; Uleu C; Ionescu DD; Nicolae T; Codorean I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(1):43-54. PubMed ID: 6125011
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE TREATMENT OF DECOMPENSATED HEART DISEASES WITH A NEW DIGITALIC DRUG (DESACETYLLANATOSIDE C)].
    CASTALDI D; PANFILI A
    Gazz Med Ital; 1963 Sep; 122():287-92. PubMed ID: 14092752
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of adrenal hormones on the cardiotonic and toxic actions of lanatoside C].
    POLDRE A; TAESCHLER M
    Helv Physiol Pharmacol Acta; 1956; 14(2):C37-C38. PubMed ID: 13345238
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with desacetyl-lanatoside-C].
    De Lutterotti A
    Clin Ter; 1965 Aug; 34(4):300-7. PubMed ID: 5321635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.